COULTER PHARMACEUTICALS INC
S-3, EX-23.1, 2000-08-30
PHARMACEUTICAL PREPARATIONS
Previous: COULTER PHARMACEUTICALS INC, S-3, EX-5.1, 2000-08-30
Next: MCGLEN INTERNET GROUP INC, 10QSB/A, 2000-08-30



<PAGE>   1

                                  EXHIBIT 23.1

               CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS


       We consent to the reference to our firm under the caption "Experts" in
the Registration Statement (Form S-3 No. 33-_____) and related Prospectus of
Coulter Pharmaceutical, Inc. for the registration of 1,655,000 shares of its
Common Stock and to the incorporation by reference therein of our report dated
January 27, 2000, with respect to the consolidated financial statements of
Coulter Pharmaceutical, Inc. included in its Annual Report (Form 10-K) for the
year ended December 31, 1999 filed with the Securities and Exchange Commission.

Palo Alto, California
August 28, 2000

                                                   /s/ ERNST & YOUNG LLP


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission